FTSE MIB
34.235,05 +295,30 (+0,87%) Dow Jones
38.249,60 +163,80 (+0,43%) Nasdaq
15.877,95 +266,19 (+1,71%) Nikkei 225
37.934,76 +306,28 (+0,81%) Petrolio
84,04 +0,47 (+0,56%) Bitcoin EUR
60.066,32 +984,31 (+1,67%)
Bio-Path Holdings, Inc. (BPTH)
| Chiusura precedente | 2,6350 |
| Aperto | 2,6400 |
| Denaro | 1,8400 x 200 |
| Lettera | 3,3100 x 200 |
| Min-Max giorno | 2,5000 - 2,6400 |
| Intervallo di 52 settimane | 2,3500 - 44,8000 |
| Volume | |
| Media Volume | 1.445.593 |
| Capitalizzazione | 3,984M |
| Beta (5 anni mensile) | 0,38 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -33,6300 |
| Prossima data utili | 10 mag 2024 - 14 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 40,00 |
GlobeNewswireBio-Path Holdings to Present at H.C. Wainwright 25th Annual Global Investment Conference
HOUSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that Peter Nielsen, Chief Executive Officer, will participate in a pre-recorded presentation at the H.C. Wainwright 25th Annual Global Investment Conference made available on Monday, September 11, 2023 at 7:00 a.m. ET. An audio webc
- GlobeNewswire
Bio-Path Holdings Reports Second Quarter 2023 Financial Results
Conference Call to be Held Today at 8:30 A.M. ETHOUSTON, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the second quarter ended June 30, 2023 and provided an update on recent corporate developments. "Our clinical progress this quarter was highlighted by the comp
- GlobeNewswire
Bio-Path Holdings to Announce Second Quarter 2023 Financial Results on August 15, 2023
HOUSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a live conference call and audio webcast on Tuesday, August 15, 2023 at 8:30 a.m. ET to report financial results for the second quarter ended June 30, 2023 and to provide a business overview. To access the live conferenc
